Each month, the CDI team rounds up some of the latest #GIcommunity research, news, and trends, and how they impact functional GI diagnostics and treatment of patients worldwide.
This month, our roundup features highlights and recording from the latest Functional GI Trends Webinar, a report on two new breath test validation studies, an article on a study linking IBS and psychological stress, and a podcast discussing SIBO, IMO, and functional GI diagnostics.
Year-End 2022 + Outlook 2023 Functional GI Trends
Following ACG 2022, CDI and My Total Health gathered an expert GI panel to help break down timely themes, hot topics, and new research discussed during the annual ACG Scientific Meeting. The panelists also provided an outlook on what’s to come in 2023 for the GI community. Topics discussed included new and emerging technologies, diets, treatments for functional GI disorders, and nonpharmacological treatments, including probiotics and prebiotics.
Data Show Breath Testing Can Help Hone Rx for Functional GI Symptoms
Gastroenterology & Endoscopy News reports this month that two new studies support the value of utilizing hydrogen and methane breath tests to improve treatment plans for patients with common functional GI symptoms.
In a trial by investigators at Cedars-Sinai, researchers found that “using breath tests to identify gut gas profiles can lead to more personalized and effective therapies” for patients with IBS.
In a trial by investigators at Weill Cornell Medical, researchers found that “patients with sucrose malabsorption often present with IBS symptoms” and that “noninvasive [carbohydrate malabsorption] breath tests may be useful in distinguishing between these conditions.”
Study finds link between IBS symptoms and stress
According to a study published in Frontiers of Neuroscience by Tokyo University of Science researchers, mice subjected to psychological stress showed diarrhea-type IBS-like symptoms without causing inflammation or structural changes in the gut. Prior studies primarily focused on physical stress, so this study is significant in focusing on psychological stress. MedicallNewsToday reports that the mice exposed to psychological stress during the trial showed “altered gut motility and increased abdominal pain sensitivity without structural damage to the gut, suggesting its suitability as an animal model for stress-induced IBS.”
CDI’s Craig Strasnick Featured in The Root Cause Medicine Podcast with Dr. Carrie Jones
During a recent episode of The Root Cause Medicine Podcast, CDI’s President & CEO Craig Strasnick discussed small intestinal bacterial overgrowth (SIBO) and intestinal methanogen overgrowth (IMO) and how the diagnostic side of GI disturbances provides essential data that helps guide research and the development of therapies to help patients find relief.